Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation

Details for Australian Patent Application No. 2006319716 (hide)

Owner Ambrilia Biopharma Inc.

Inventors Milot, Guy; Branchaud, Stephane; Stranix, Brent Richard

Agent Peter Maxwell & Associates

Pub. Number AU-B-2006319716

PCT Pub. Number WO2007/062526

Priority 60/740,642 30.11.05 US

Filing date 30 November 2006

Wipo publication date 7 June 2007

Acceptance publication date 2 February 2012

International Classifications

C07F 9/09 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/062526 Priority application(s): WO2007/062526

2 February 2012 Application Accepted

  Published as AU-B-2006319716

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319727-Device for fastening a covering profile for the transition between two surfaces perpendicular to each other

2006319712-Novel hydroxysteroid dehydrogenase gene for alteration of plant phenotype